Article

Diet-Induced Weight Loss Beneficial to Knee Osteoarthritis

Low-energy diet–induced weight loss leads to independent losses of leg muscle tissue and absolute knee muscle strength in obese patients with knee osteoarthritis (OA).

Low-energy diet–induced weight loss leads to independent losses of leg muscle tissue and absolute knee muscle strength in obese patients with knee osteoarthritis (OA). However, the weight loss is accompanied by increased normalized muscle strength and improved self-reported disability and pain, offering benefits to patients with knee OA.

Henriksen and coworkers studied 159 obese patients with knee OA using data from a body composition analysis and isometric muscle strength testing of the knee. The data had been obtained as part of a randomized controlled trial; measurements were performed before and after a 16-week supervised low-energy diet–induced weight loss intervention.

The patients lost an average of 12.9 kg, or 13% of baseline weight, consisting of 10.9 kg fat mass, of which 3.8 kg was leg fat mass. Total lean body mass was reduced by 1.9 kg, of which 0.785 kg was leg lean mass. Absolute muscle strength decreased by about 3% or 4% after the weight loss; body mass–normalized muscle strength increased by 11% to 12%. Leg lean mass was significantly related to muscle strength at baseline.

The authors suggested that weight loss efforts in patients who have knee OA be combined with efforts to restore or add muscle mass.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.